
Trius Therapeutics Reports 2010 Fourth Quarter and Full Year Financial Results
SAN DIEGO, March 23, 2011 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections, announced today its financial results for the […]